InvestorsHub Logo
Followers 2
Posts 2022
Boards Moderated 0
Alias Born 05/11/2017

Re: hovacre post# 96869

Wednesday, 04/03/2019 1:52:45 PM

Wednesday, April 03, 2019 1:52:45 PM

Post# of 108192
Berlin stated:"“Based on the prolonged survival data and strong safety profile to date, we believe that continued clinical development of ADXS-PSA in combination with KEYTRUDA [® ] is warranted and represents a potentially significant opportunity for Advaxis.”

So, someone IS lying: Either Dr Beer or our CEO. We have seen re-tweets of someone who was singing Beer's tunes by Fuhrestein two days ago. Dew rebutted them on twitter.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News